Overview
CATALYST is designed to provide temporary hemostasis and enhance coagulation for patients requiring manual compression – helping to reduce mean hold time by over 50% and reduce time to ambulation by more than 20% as compared to manual compression.2
The CATALYST II and CATALYST III manual compression assist devices employ Cardiva’s proven proprietary collapsible disc technology and two different hemostatic coatings based on the presence of heparin. CATALYST II is coated with kaolin and chitosan used to promote coagulation by activating the clotting cascade and causing platelet aggregation. CATALYST III is coated with an additional drug, protamine sulfate, acting locally to neutralize heparin and further aid the body’s natural healing process.
2Data from BOOM II Investigator-Initiated Clinical Study with manuscript submitted for publication. Note: FDA has not reviewed reduced TTH or TTA data.